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Her mother developed diabetic neuropathy in her feetthat progressed to gangrene. Finallyit became so advanced that she required.an amputation -and died on the day she was to undergo surgery.
She was 67 years old.
Sharon Wade, now 48, herself was diagnosed with diabetes eight years ago and developed neuropathy about five years later. So when she learned of a study involving magnetic energy as a treatment for diabetic neuropathy, she took notice. Neuropathy, or nerve damage, affiicts 50 percent to 70 percent of the 21 million Americans with diabetes. The causes haven't been completelyidentified,but theyarethoughtto includeprolonged exposure to the high blood sugar levels characteristic of diabetes, genetic factors, and damage to the blood vessels that carry oxygen and nutrients to the nerves. The energy is provided through a device called the BiaxialBody Energizer. The energizer resembles a bathroom scale, with two severe neuropathy. He randomly assigned patients to wear either the magnetized insole or a sham device. This trial was double-blind, meaning that neither he nor the participants knew which group they were in until the study was over. Patients who wore the real device experienced a statistically significant decrease in pain, burning and tingling, as well as a significant improvement in walking, over the individuals in the comparison grQup.
"The analgesic effects were equal to or , better than those achieved with painkilling drugs, and there were no side effects,with a device that costs about $100 apiece," Dr. Weintraub reports. For the current trial, Dr. Weintraub and his associates want to recruit 250 volunteers with moderate to severe neuropathy at 12 to 15 university diabetes centers and 10 private medical groups nationwide.
This stUdy also is double-blind, so the parThree magnets in each of the energizer's footplates are designed to deliver therapeutic waves. ticipants are randomly assigned either to a working energizer or a sham device that feels as if it's working but is not actually delivering any magnetic energy: Neither they nor any of the investigators will know which type of device they've received until the study is completed.
The participants undergo an objective assessment of nerve function just before they start using the device and again when the 90-day study period is up. They are also required to keep a daily log in which they rate their pain on a scale ranging from 0 (nonexistent) to 10 (most severe). In addition, the researchers will compare biopsies taken from 40 randomly selected patients with foot ulcers before and after their participation in the study:
The participants may not know if they have a real or sham energizer, but some volunteers -including Sharon Wade -are already reporting benefits.
"I've seen a remarkable improvement," says Wade. "My feet used to become crampy and swollen, and I had trouble walking, but no longer." It took a little over a month for Wade to see any effects. But relief came faster for another study participant, Carol Thorn. "My feet stopped burning and tingling within a day or two," Thorn says.
Thorn was diagnosed with diabetes about 15 years ago, when she was 50. She finished her official three-month stint with the device just before last Christmas. She still doesn't know if her unit was a sham or the real thing, but she found it so helpful nevertheless that she kept it and continues to use it. Volunteers are allowed to keep the device, which is manufactured and provided by the Nikken Corp. of Irvine, Calif.
The energizer weighs three pounds. Its light and convenient enough for Wade, who lives in the Bronx, to take to her job as a social worker so she can use it for the requisite two hours a day while sitting at her desk. Thorn, who lives in Fishkill, N.Y., took hers on her Christmas vacation: She simply packed it in her suitcase and checked it on the airplane. "Wewant to offerthe diabetic population a truly effective treatment for neuropathy," Dr. Weintraub says. 'We're hoping that this study willprovide the objective evidence we need to demonstrate that the device relieves neuropathic symptoms."
Carol Thorn, for one, is convinced.
"The machine is great," she declares. "I don't want to let it go." 1m! . '.
